细胞裂解市场－全球产业规模、份额、趋势、机会和预测，按产品类型、细胞类型、最终用户、地区和竞争细分，2020-2030 年

2024 年全球细胞裂解市场价值为 31.6 亿美元，预计到 2030 年将达到 48.7 亿美元，预测期内复合年增长率为 7.47%。由于製药、生物技术和医疗保健领域对基于细胞的研究和诊断应用的需求不断增加，该市场正在经历显着增长。细胞裂解——破坏细胞以获取其内部成分——是分子生物学、生物加工和临床诊断的基础步骤。

生物製药产业的扩张以及向标靶治疗和个人化医疗的转变加剧了对高效细胞裂解技术提取蛋白质、DNA 和 RNA 的需求。同时，基因组学和蛋白​​质组学的进步正在加速先进裂解技术的应用。随着研究人员专注于从各种细胞类型中分离生物分子，对精确且可扩展的细胞裂解方法的需求持续成长。应用范围的不断扩大强化了细胞裂解作为治疗发展和分子诊断中的关键推动因素的地位。

关键市场驱动因素

生物製药进展

主要市场挑战

细胞裂解设备和试剂成本高昂

主要市场趋势

生物製剂和个人化医疗需求不断增长

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球细胞裂解市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依产品类型（仪器{均质机、离心机、其他类型的产品}、试剂）
  • 依细胞类型（哺乳动物细胞、微生物细胞、植物细胞）
  • 按最终用户（生物技术或生物製药公司、研究实验室和学术机构、其他最终用户）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美细胞裂解市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲细胞裂解市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太细胞裂解市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美细胞裂解市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲细胞裂解市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章： 大环境分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Becton, Dickinson and Company
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Eppendorf AG
• Hoffmann-La Roche Ltd
• Labfreez Instruments Group Co. Ltd
• Merck KGaA
• Qsonica LLC
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Cell Lysis Market was valued at USD 3.16 billion in 2024 and is projected to reach USD 4.87 billion by 2030, growing at a CAGR of 7.47% during the forecast period. This market is witnessing significant growth due to the increasing demand for cell-based research and diagnostic applications in the pharmaceutical, biotechnology, and healthcare sectors. Cell lysis-breaking open cells to access their internal components-is a foundational step in molecular biology, bioprocessing, and clinical diagnostics.

The biopharmaceutical industry's expansion and the shift toward targeted therapies and personalized medicine have intensified the need for efficient cell lysis techniques to extract proteins, DNA, and RNA. In parallel, advancements in genomics and proteomics are accelerating the adoption of advanced lysis technologies. As researchers focus on biomolecular isolation from various cell types, the demand for precise and scalable cell lysis methods continues to grow. This rising application spectrum reinforces cell lysis as a critical enabler in both therapeutic development and molecular diagnostics.

Key Market Drivers

Biopharmaceutical Advancements

The accelerating growth of the biopharmaceutical industry is a central force driving the global cell lysis market. With increasing focus on biologics and personalized medicine, pharmaceutical companies rely on advanced cell lysis methods to extract therapeutic proteins, DNA, and RNA.

Cell lysis enhances the efficiency of drug development by facilitating rapid extraction and purification of target biomolecules. This is crucial for reducing time-to-market, especially during health crises where expedited drug development is vital. Biomanufacturing processes, including antibody and protein production, depend on optimized lysis techniques to increase yield and maintain product quality.

As the complexity of therapeutic molecules increases, advanced cell lysis tools help ensure high purity and minimize contamination, which is essential for patient safety and regulatory compliance. This growing reliance on cell lysis across the drug discovery and development lifecycle ensures sustained demand for high-performance lysis products and systems.

Key Market Challenges

High Cost of Cell Lysis Equipment and Reagents

A notable challenge in the global cell lysis market is the high cost associated with equipment and reagents. High-performance instruments, such as automated and high-pressure lysis systems, require significant capital investment, which can restrict access for smaller laboratories or institutions with limited funding.

Moreover, premium-grade reagents-including enzymes, detergents, and buffers-are necessary for specific applications but can be prohibitively expensive for routine use, especially in developing countries. This limits the adoption of advanced lysis solutions and contributes to disparities in research capabilities across different regions.

Budget constraints in academic or underfunded institutions further exacerbate this issue, potentially hindering innovations in therapeutic and diagnostic research where reliable lysis techniques are essential.

Key Market Trends

Rising Demand for Biologics and Personalized Medicine

A prominent trend shaping the cell lysis market is the increasing focus on biologics and personalized therapies. The development of complex biologics-such as monoclonal antibodies, gene therapies, and vaccines-requires efficient cell lysis processes for the extraction of high-quality biomolecules.

As personalized medicine gains traction, diagnostic labs are using cell lysis to isolate DNA, RNA, and proteins for genetic profiling and biomarker analysis. This enables clinicians to tailor treatments based on individual patient data, improving efficacy and minimizing side effects.

With the biopharmaceutical industry continuously innovating in molecular and precision medicine, cell lysis systems are evolving to support specific needs in both upstream and downstream processes, ensuring compatibility with high-throughput, scalable workflows.

Key Market Players

• Becton, Dickinson and Company
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Eppendorf AG
• Hoffmann-La Roche Ltd
• Labfreez Instruments Group Co. Ltd
• Merck KGaA
• Qsonica LLC
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.

Report Scope:

In this report, the Global Cell Lysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Lysis Market, By Type of Product:

• Instruments
• Reagents

Cell Lysis Market, By Type of Cells:

• Mammalian Cells
• Microbial Cells
• Plant Cells

Cell Lysis Market, By End User:

• Biotechnology or Biopharmaceutical Companies
• Research Laboratories and Academic Institutes
• Other End Users

Cell Lysis Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Lysis Market.

Available Customizations:

Global Cell Lysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Lysis Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type of Product (Instruments {Homogeniser, Centrifugation, Other Types of Products}, Reagents)
  • 5.2.2. By Type of cells (Mammalian Cells, Microbial Cells, Plant Cells)
  • 5.2.3. By End user (Biotechnology or Biopharmaceutical Companies, Research Laboratories and Academic Institutes, Other End Users)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Cell Lysis Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type of Product
  • 6.2.2. By Type of cells
  • 6.2.3. By End user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cell Lysis Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Product
      • 6.3.1.2.2. By Type of cells
      • 6.3.1.2.3. By End user
  • 6.3.2. Mexico Cell Lysis Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Product
      • 6.3.2.2.2. By Type of cells
      • 6.3.2.2.3. By End user
  • 6.3.3. Canada Cell Lysis Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Product
      • 6.3.3.2.2. By Type of cells
      • 6.3.3.2.3. By End user

7. Europe Cell Lysis Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type of Product
  • 7.2.2. By Type of cells
  • 7.2.3. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cell Lysis Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Product
      • 7.3.1.2.2. By Type of cells
      • 7.3.1.2.3. By End user
  • 7.3.2. Germany Cell Lysis Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Product
      • 7.3.2.2.2. By Type of cells
      • 7.3.2.2.3. By End user
  • 7.3.3. United Kingdom Cell Lysis Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Product
      • 7.3.3.2.2. By Type of cells
      • 7.3.3.2.3. By End user
  • 7.3.4. Italy Cell Lysis Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Product
      • 7.3.4.2.2. By Type of cells
      • 7.3.4.2.3. By End user
  • 7.3.5. Spain Cell Lysis Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Product
      • 7.3.5.2.2. By Type of cells
      • 7.3.5.2.3. By End user

8. Asia-Pacific Cell Lysis Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type of Product
  • 8.2.2. By Type of cells
  • 8.2.3. By End user
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cell Lysis Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Product
      • 8.3.1.2.2. By Type of cells
      • 8.3.1.2.3. By End user
  • 8.3.2. India Cell Lysis Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Product
      • 8.3.2.2.2. By Type of cells
      • 8.3.2.2.3. By End user
  • 8.3.3. South Korea Cell Lysis Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Product
      • 8.3.3.2.2. By Type of cells
      • 8.3.3.2.3. By End user
  • 8.3.4. Japan Cell Lysis Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Product
      • 8.3.4.2.2. By Type of cells
      • 8.3.4.2.3. By End user
  • 8.3.5. Australia Cell Lysis Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Product
      • 8.3.5.2.2. By Type of cells
      • 8.3.5.2.3. By End user

9. South America Cell Lysis Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type of Product
  • 9.2.2. By Type of cells
  • 9.2.3. By End user
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cell Lysis Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Product
      • 9.3.1.2.2. By Type of cells
      • 9.3.1.2.3. By End user
  • 9.3.2. Argentina Cell Lysis Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Product
      • 9.3.2.2.2. By Type of cells
      • 9.3.2.2.3. By End user
  • 9.3.3. Colombia Cell Lysis Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Product
      • 9.3.3.2.2. By Type of cells
      • 9.3.3.2.3. By End user

10. Middle East and Africa Cell Lysis Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type of Product
  • 10.2.2. By Type of cells
  • 10.2.3. By End user
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cell Lysis Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Product
      • 10.3.1.2.2. By Type of cells
      • 10.3.1.2.3. By End user
  • 10.3.2. Saudi Arabia Cell Lysis Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type of Product
      • 10.3.2.2.2. By Type of cells
      • 10.3.2.2.3. By End user
  • 10.3.3. UAE Cell Lysis Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Product
      • 10.3.3.2.2. By Type of cells
      • 10.3.3.2.3. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Becton, Dickinson and Company
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Bio-Rad Laboratories Inc.
• 15.3. Danaher Corporation
• 15.4. Eppendorf AG
• 15.5. Hoffmann-La Roche Ltd
• 15.6. Labfreez Instruments Group Co. Ltd
• 15.7. Merck KGaA
• 15.8. Qsonica LLC
• 15.9. Takara Bio Inc.
• 15.10. Thermo Fisher Scientific Inc.

16. Strategic Recommendations

17. About Us & Disclaimer